P726: MYELOID-DERIVED SUPPRESSOR CELLS AS POTENTIAL TARGETS FOR IMMUNE THERAPY IN CCUS AND LOW RISK MDS

P726: MYELOID-DERIVED SUPPRESSOR CELLS AS POTENTIAL TARGETS FOR IMMUNE THERAPY IN CCUS AND LOW RISK MDS

Bibliographic Details
Main Authors:	S. Bentivegna, M. O. Holmström, M. H. Andersen, K. Grønbæk
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000845788.69394.3c

Similar Items

Myeloid-Derived Suppressor Cells: New Insights into the Pathogenesis and Therapy of MDS
by: Maria Velegraki, et al.
Published: (2022-08-01)

CD123-Directed Bispecific Antibodies for Targeting MDS Clones and Immunosuppressive Myeloid-Derived Suppressor Cells (MDSC) in High-Risk Adult MDS Patients
by: Fatih M. Uckun, et al.
Published: (2021-09-01)

Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
by: Graham Pawelec, et al.
Published: (2019-05-01)

Targeting Myeloid-Derived Suppressor Cells in Ovarian Cancer
by: Seiji Mabuchi, et al.
Published: (2021-02-01)

Targeting Myeloid-Derived Suppressor Cells in Cancer Immunotherapy
by: Yufei Wang, et al.
Published: (2020-09-01)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
by: Francesca Maria Consonni, et al.
Published: (2019-05-01)

Targeting myeloid-derived suppressor cells for cancer therapy
by: Hongchao Tang, et al.
Published: (2021-11-01)

Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion
by: Junli Lu, et al.
Published: (2024-04-01)

Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer
by: Andrew M. K. Law, et al.
Published: (2020-02-01)

The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
by: Paola De Cicco, et al.
Published: (2020-07-01)

Immunomodulatory actions of myeloid-derived suppressor cells in the context of innate immunity
by: Nikoleta Bizymi, et al.
Published: (2024-01-01)

Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers
by: Junaid Arshad, et al.
Published: (2024-03-01)

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
by: Yuze Wu, et al.
Published: (2022-09-01)

Myeloid derived suppressor cells as therapeutic target in hematological malignancies
by: Kim eDe Veirman, et al.
Published: (2014-12-01)

Targeted inhibition of myeloid-derived suppressor cells in the tumor microenvironment by low-dose doxorubicin to improve immune efficacy in murine neuroblastoma
by: Wei-Li Xu, et al.
Published: (2021-02-01)

Myeloid-Derived Suppressor Cells: The Expanding World of Helminth Modulation of the Immune System
by: Mary M. Stevenson, et al.
Published: (2022-06-01)

Myeloid-derived suppressor cells in Chronic myeloid leukemia
by: Cesarina eGiallongo, et al.
Published: (2015-05-01)

Targeting myeloid-derived suppressor cells (MDSCs) with immune checkpoint inhibitors for treating cisplatin-resistant bladder cancer
by: Y. Takeyama, et al.
Published: (2020-07-01)

Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease
by: Ching-Chuan Hsieh, et al.
Published: (2022-10-01)

Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity
by: Elliot D. Kramer, et al.
Published: (2020-08-01)

NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion
by: Ying Wu, et al.
Published: (2022-06-01)

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
by: Aohan Hou, et al.
Published: (2020-05-01)

Myeloid-Derived Suppressor Cells in Sepsis
by: Irene T. Schrijver, et al.
Published: (2019-02-01)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
by: Viktor Fleming, et al.
Published: (2018-03-01)

Clinical Perspectives on Targeting of Myeloid Derived Suppressor Cells in the Treatment of Cancer
by: Yana George Najjar, et al.
Published: (2013-03-01)

Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment
by: Xidan Gao, et al.
Published: (2021-02-01)

Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
by: Kai Li, et al.
Published: (2021-10-01)

CCUS: The Road to Net-Zero
by: Humbul Suleman, et al.
Published: (2023-05-01)

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
by: Nabanita Mukherjee, et al.
Published: (2024-03-01)

Myeloid-Derived Suppressor Cells in Lung Transplantation
by: Tobias Heigl, et al.
Published: (2019-04-01)

The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
by: Yajing Mi, et al.
Published: (2020-04-01)

Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
by: Srivastava MK, et al.
Published: (2012-10-01)

Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets
by: Nikoleta Bizymi, et al.
Published: (2019-02-01)

Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers
by: Seiji Mabuchi, et al.
Published: (2021-04-01)

Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond
by: Yang Zhao, et al.
Published: (2023-03-01)

Epigenetic targeting of myeloid-derived suppressor cells: time to move into infectious diseases?
by: Morten Frier Gjerstorff, et al.
Published: (2023-08-01)

Overcoming resistance to immunotherapy by targeting GPR84 in myeloid-derived suppressor cells
by: Guohui Qin, et al.
Published: (2023-04-01)

The recent progress of myeloid‐derived suppressor cell and its targeted therapies in cancers
by: Ruiyang Ren, et al.
Published: (2023-08-01)

The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers
by: Rong Fan, et al.
Published: (2022-10-01)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
by: Mohammad A. Al-Mterin, et al.
Published: (2022-08-01)